1. Home
  2. ESNT vs ICUCW Comparison

ESNT vs ICUCW Comparison

Compare ESNT & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESNT
  • ICUCW
  • Stock Information
  • Founded
  • ESNT 2008
  • ICUCW N/A
  • Country
  • ESNT Bermuda
  • ICUCW United States
  • Employees
  • ESNT N/A
  • ICUCW 18
  • Industry
  • ESNT Property-Casualty Insurers
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESNT Finance
  • ICUCW Health Care
  • Exchange
  • ESNT Nasdaq
  • ICUCW Nasdaq
  • Market Cap
  • ESNT N/A
  • ICUCW N/A
  • IPO Year
  • ESNT 2013
  • ICUCW 2021
  • Fundamental
  • Price
  • ESNT $64.60
  • ICUCW $0.05
  • Analyst Decision
  • ESNT Buy
  • ICUCW
  • Analyst Count
  • ESNT 6
  • ICUCW 0
  • Target Price
  • ESNT $63.67
  • ICUCW N/A
  • AVG Volume (30 Days)
  • ESNT 467.6K
  • ICUCW N/A
  • Earning Date
  • ESNT 10-31-2025
  • ICUCW N/A
  • Dividend Yield
  • ESNT 1.94%
  • ICUCW N/A
  • EPS Growth
  • ESNT N/A
  • ICUCW N/A
  • EPS
  • ESNT 6.85
  • ICUCW N/A
  • Revenue
  • ESNT $1,268,306,000.00
  • ICUCW N/A
  • Revenue This Year
  • ESNT $4.27
  • ICUCW N/A
  • Revenue Next Year
  • ESNT $1.47
  • ICUCW N/A
  • P/E Ratio
  • ESNT $9.32
  • ICUCW N/A
  • Revenue Growth
  • ESNT 5.28
  • ICUCW N/A
  • 52 Week Low
  • ESNT $51.61
  • ICUCW N/A
  • 52 Week High
  • ESNT $65.34
  • ICUCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • ESNT 63.17
  • ICUCW N/A
  • Support Level
  • ESNT $62.44
  • ICUCW N/A
  • Resistance Level
  • ESNT $64.42
  • ICUCW N/A
  • Average True Range (ATR)
  • ESNT 1.04
  • ICUCW 0.00
  • MACD
  • ESNT -0.12
  • ICUCW 0.00
  • Stochastic Oscillator
  • ESNT 74.73
  • ICUCW 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: